Join | Login







 

 

Required Materials

Bronze = $2,500 Silver = $4,000 Gold = $7,000 Platinum = $12,000+

Timeline

 
Renewals for Sponsorships
 Company  Contact  Email  Website  Prev Lvl  Offered  Paid  Notes by #
 Abbott Nutrition  Terry Dimitratos  terry.dimitratos@abbott.com

julie.st-pierre@abbott.com

   Gold    *Terry to reply to email Aug 19  1, 1b, 1c, 1d, 1e, 1f, 1h
 Ajinmoto/Cambrooke

 Stephanie Lemay

Karen Gough

slemay@cambrookefoods.com

k.gough@cambrookefoods.com

   Silver  Silver $2482.50 CAD ($2500 less bank fee of $17.50)

 

$1500 in low protein foods

 1, 1b, 1c, 1d, 1e, 6
 Biomarin        Platinum  30,000 so far

 6200+30,000 in Jan

$1554.50 CAD Honourarium from Tanya attending EUCAN

 4, 7
 Galen Pharma

 Simon Lawrence

Amrik Mall

simon.lawrence@galen-pharma.com

amrik.mall@galen-pharma.com

   Silver Silver - Inv 853  8/9/24 $5,309.64 CAD ($4000 USD)   1,3, 6A, 6B
 Homology (merged and became Q32)

 Theresa McNeely

Marisa Citrano

 tmcneely@homologymedicines.com

mcitrano@homologymedicines.com

   D2T 5,000      1, 1b, 1c
 Innomar Strategies  Krystal Austin  krystal.austin@cencora.com    Bronze  Bronze 2500  Feb 8, 2024  1, 1c, 6
 Innovative Medicines Canada  Hugh Scott  hscott@imc-mnc.ca    Gold      9
 Nutricia

 Justine Bourgeois 

 Anthony Guerriero

Justine.BOURGEOIS@danone.com

anthony.guerriero@danone.com

   Silver  Silver  2023, 03,06  
 PhRMA        Platinum Platinum    7A, 7B
 PTC Therapeutics  Anne Bruns  abruns@ptcbio.com    Platinum  Platinum

 $15,767.78

Feb 15 24

 1, 6
 Rx Modality  Petr Formanek  petr.formanek.rmx@gmail.com    Bronze  Bronze  2024, 01 30  1, 1b
 Science 37  Ruth Rogers ruth.rogers@science37.com    Gold  None

Feb 22, 2024

$6K ($7803.50 CAD) 

 1, 2, 6
 Synlogics

 Molly Harper

Dan Rosan

Lori McKenna Gorski

Molly.Harper@synlogictx.com

Dan.Rosan@synlogictx.com Lori.McKenna.Gorski@synlogictx.com

 

 Platinum

 

 Platinum Inv 891

 

 Trial closed before payment  1, 1b, 6, 8
 Vitaflo

 Michelle Harrington

Elise Pelletier

Maria Cunto

Michelle.Harrington@vitaflousa.com

Elise.Pelletier@vitaflo.ca

maria.cunto@vitaflousa.com

   Silver  $4000 May 7th, 2024    1, 1b, 1c, 5, 6, 1d
Solace Nutrition, LLC       Kate Murtaugh     kmurtaugh@solacenutrition.com None  Silver  $4000 JUL 24 PAID 7/24/24 $4,000.01 CAD ($3000 USD)

 1c 1d 6 1g

First Play df (promin)  Mark Kerrigan  mark.kerrigan@firstplaydf.com     Foods     1, 1b, 14
Dr Reddy  Vinod Ramachandran PhD vramachandran@drreddys.com   KUVAN GENERIC BRONZE OFFERED    1D, 1C

                        Robert Herrington rherrington@drreddys.com INVOICE SENT 2/16

SPONSOR SAID MAY 16TH PMT PAID MAY15TH

2000 - 17.50 fees

Recordati Rare Disease       France Lelel Sr Director Med affairs   lebel.f@recordati.com       www.recordatirarediseases.com/ca      1, 1b, 1c

Isabel De Araujo, Sr Med Sc Liaison Med Affairs   araujo.i@recordati.com     

Stated if we have a project they will fund. Doesnt do blanket funding 

LOOKING TO PARTNER WITH A WELLNESS PACKAGE

Notes by Number

See last column of above table to reference the notes here.

1 - Sent invitation to sponsor Dec 6, 2023 by Tanya

1b - Sent reminder Jan 18, 2024 by Tanya

1c - Reminder sent Feb 8, 2024 by Tanya

1d - Reminder sent April 30, 2024 by tanya

1e - Reminder sent May 15th by Tanya

1f - Made a call seeking to reach sponsor. No answer. Left Message June 27 by tanya

1g - Reminder sent Jun 27 by tanya (email)

1h - Aug 1 - REminder sent

2 - Declined sponsorship as no active contracts. Will continue to try and fit us into their needs this year.

3 - Galen runs one year behind. So this year is actually paying for 2023 and we reach out in Q4 regarding the current years sponsorship until the time they can do two in one year. This is the result of them honouring an agreement that was made with a different person, but not paid forward to us.

4 - First 6 months at 30,000 CAD was allocated from the 2023 budget, John was late in applying for grant/ problem with payment processor caused this to come from 2024 budget. Unsure if this will affect donation amount. 

 5 - Asked about Chef Neil for the BC event.

6 - Checking with accounting regarding payment or been submitted to accounting

6A - Emailed to look into unpaid invoice.

6B - Resent invoice. Awaiting Payment

7 - Asked John when to apply next - Reply from John, Every 6 months. John confirmed end of May start of June would be application date. Waiting on John as he still handles Biomarin

7A - John met with Phrma in Feb. Unsure discussions. Last payment Dec 5, 2023. John handles Phrma as it is a unique sponsorship. talking to Phrma July 2024

7B - Jul 18 message from John - Meeting with PhRMA yesterday morning went well. They promised an early decision on 2024 sponsorship. 

8, Spoke to Angela Kurtz at GMDI and she suggested she may have a contact who is tying up loose ends of Synlogic and paying out any final bills. She will look into potential getting us some of the promised scholarship.

9. Submitted application to IMC - Document

14 - Offered supply of food samples, and requested we ask again in July about sponsorship - emailed a follow up June 27

 

 

New Considerations for Sponsorship

 Company  Contact  Email  Website  Rare  Offered  Paid  Notes by #
 Travere  Eve eve.dryer@travere.com    HCU      1c, 1d
               
 National Foods  Roman

 

 

   Food       1, 1b
 Dr. Schar USA Inc              
 Mead Johnson  

Gina.macdonald@rb.com

Angela.Morcone@reckitt.com

   Formula      
 Nestle Health Sciences              
 Jnana Therapeutics Joanne Kotz, PhD jkotz@jnanatx.com https://www.jnanatx.com/ PKU    

 10, 1, 1b, 1c

 

First Play df (promin) Mark Kerrigan mark.kerrigan@firstplaydf.com    Foods    

 1, 1b, 14

Paolo Galfetti CEO
Company Contact  email  Website  Rare  Offered Paid   Notes by #
APR (PKU GOLIKE)
Paolo Galfetti CEO paolo.galfetti@apr.ch         1c
               
Horizon  Anna Marie Bingo and Matt Flesch

Amgen completed its acquisition of Horizon Therapeutics plc on October 6, 2023.

Watch for connection linked in for James Bradner of amgen - ask if they will be picking up horizons work on HCU

https://www.horizontherapeutics.com/medical-resources/grant-programs/  UCDs      Sent Jan 10
Recordati Rare Disease

France Lelel Sr Director Med affairs

Isabel De Araujo, Sr Med Sc Liaison Med Affairs 

lebel.f@recordati.com

araujo.i@recordati.com

www.recordatirarediseases.com/ca

   Stated if we have a project they will fund. Doesnt do blanket funding    1, 1b, 1c
Medunik  

 tried to call. no luck

added contacts in linkin

https://medunikcanada.com/en/rare-diseases-community  HCU      11
Acer Therapeutics    sent email to investors@acertx.com 

 asking for better contact

bpaul@acertx.com - email sent via linkedin connection

https://www.acertx.com/ UCD and OTC treatment MSUD Pipeline  FAILED    1c
Dr Reddy Vinod Ramachandran PhD

VP & GM

Robert Herrington

vramachandran@drreddys.com

rherrington@drreddys.com

www.drreddys.ca

Kuvan Generic  Bronze

 Invoice sent 2/16

1d

 1c
Biotherapeutics Codexis

 Gjalt Huisman, VP -

650 - 421-8206

 gjalt.huisman@codexis.com  

 PKU

HCU

MSUD

     
Ultragenix     https://www.ultragenyx.com/canadian-english/  OTC      13
moderna  Patricia Gauthier

 patricia.gauthier@hec.ca

Country General Manager - Ask for Sales and Marketing rep 

Adv page shows PKU when google searched but not when looking at site - broken link.

** Sent email 2/8

         
Cycle Pharmaceutical    emailed info@cyclepharma.com for better email for sponosrship    HCU      
Chiesi Global Rare Disease        NO      
Eton Pharma   info@etonpharma.com asking for email 1c https://www.etonpharma.com/  HCU      12, 1c
HemoShere Therapy        NO      
Jaguar Gene Therapy        NO      

LogicBio Thera Inc?

Alexion,

AstraZeneca Rare Disease

     

 MMA

No

No

     
Relief Therapeutics        PKU UCD MSUD      
Takeda        NO      
Amicus Therapeutics        NO      
 Q32 Bio    look into it for 2025 Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million        

Notes by Number

See last column of above table to reference the notes here.

Drop Aeglea as a sponsor potential. Acquired by another company who is focused on IBD. Trial for the HCU drug did not go well.

1 - Sent invitation to sponsor Dec 6, 2023 - by Tanya

1b - Sent follow up Jan 18th, 2024 - by Tanya

1c - Sent Feb 5 - By Tanya

1d - sent reminder apr 30 by tanya

2 - Email returned - bad email

3 - Company indicated sponsorship

4 - Company paid sponorship

5 - Sponsorship page has been updated

10 - PKU trial now enrolling

11 - Mednuik pheburane - ucd avail in cnada 1 844 433-4441 950, boul. Michèle-Bohec J7C 5E2

12 - HCU Meds (Betaine)

13 - https://www.ultragenyx.com/our-research/pipeline/

14 - Offered supply of food samples, and requested we ask again in July about sponsorship

 

 

 

Action Items

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 
 
 

 

 

 

 

 
 
 
 

 

 

 

 

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Discussions

Newborn Screening Ontario - For cross promotion?

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This forum is empty.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Members of the Group